Current and Future Implications of Using Artificial Intelligence in Glaucoma Care

Affiliations

¹ Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA.
² Department of Ophthalmology, Mayo Clinic Florida, Jacksonville, Florida, USA.
³ Research Collaborator Ophthalmology, Mayo Clinic Florida, Jacksonville, Florida, USA.

Editorial

Abhimanyu S Ahuja et al. J Curr Ophthalmol. 2022.

. 2022 Jul 26;34(2):129-132.

doi: 10.4103/joco.joco_39_22. eCollection 2022 Apr-Jun.

¹ Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA.
² Department of Ophthalmology, Mayo Clinic Florida, Jacksonville, Florida, USA.
³ Research Collaborator Ophthalmology, Mayo Clinic Florida, Jacksonville, Florida, USA.

No abstract available

References

1. Gunasekeran DV, Wong TY. Artificial intelligence in ophthalmology in 2020: A technology on the cusp for translation and implementation. Asia Pac J Ophthalmol (Phila) 2020;9:61–6. - PubMed
1. Thompson AC, Jammal AA, Medeiros FA. A review of deep learning for screening, diagnosis, and detection of glaucoma progression. Transl Vis Sci Technol. 2020;9:42. - PMC - PubMed
1. Lin WC, Chen JS, Chiang MF, Hribar MR. Applications of artificial intelligence to electronic health record data in ophthalmology. Transl Vis Sci Technol. 2020;9:13. - PMC - PubMed
1. Gaskin GL, Pershing S, Cole TS, Shah NH. Predictive modeling of risk factors and complications of cataract surgery. Eur J Ophthalmol. 2016;26:328–37. - PMC - PubMed
1. Fraccaro P, Nicolo M, Bonetto M, Giacomini M, Weller P, Traverso CE, et al. Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: A machine learning approach. BMC Ophthalmol. 2015;15:10. - PMC - PubMed